
BioLife Solutions BLFS
€ 23.87
5.56%
Quartalsbericht 2026-Q1
hinzugefügt 07.05.2026
BioLife Solutions Langfristige Verbindlichkeiten 2011-2026 | BLFS
Langfristige Verbindlichkeiten Jährlich BioLife Solutions
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 41.7 M | 380 K | 538 K | 3.63 M | 122 M | 875 K | 15 M | 14.3 M | 12.3 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 122 M | 380 K | 23.4 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
1.54 B | $ 68.62 | 2.74 % | $ 13.7 B | ||
|
Glaukos Corporation
GKOS
|
87.4 M | $ 126.34 | 3.59 % | $ 7.23 B | ||
|
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | ||
|
Intuitive Surgical
ISRG
|
418 M | $ 426.61 | 1.91 % | $ 152 B | ||
|
Alcon
ALC
|
6.05 B | $ 67.9 | 2.71 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
66.7 M | $ 142.0 | 3.29 % | $ 3.5 B | ||
|
iRhythm Technologies
IRTC
|
119 M | $ 113.83 | 6.15 % | $ 3.64 B | ||
|
Repro Med Systems
KRMD
|
239 K | $ 4.0 | 0.25 % | $ 185 M | ||
|
LeMaitre Vascular
LMAT
|
19.3 M | $ 96.59 | 1.56 % | $ 2.19 B | ||
|
Masimo Corporation
MASI
|
56 M | $ 179.95 | 0.01 % | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
760 K | $ 1.82 | - | $ 83.3 M | ||
|
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
11.2 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
1.4 M | $ 0.39 | 0.29 % | $ 32 M | ||
|
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | ||
|
Merit Medical Systems
MMSI
|
626 M | $ 67.51 | 2.24 % | $ 3.99 B | ||
|
electroCore
ECOR
|
1.42 M | $ 9.52 | -1.24 % | $ 80.8 K | ||
|
Envista Holdings Corporation
NVST
|
1.91 B | $ 24.59 | 4.91 % | $ 4.13 B | ||
|
Haemonetics Corporation
HAE
|
405 M | $ 78.71 | 5.11 % | $ 3.71 B | ||
|
STERIS plc
STE
|
1.53 B | $ 212.88 | 1.1 % | $ 20.9 B | ||
|
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
12.5 M | $ 29.87 | -0.3 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
35 M | $ 9.01 | - | $ 186 M | ||
|
Teleflex Incorporated
TFX
|
2.77 B | $ 135.75 | 3.04 % | $ 6.06 B | ||
|
Utah Medical Products
UTMD
|
5.25 M | $ 68.07 | 1.52 % | $ 221 M | ||
|
West Pharmaceutical Services
WST
|
427 M | $ 334.66 | 4.66 % | $ 24.2 B | ||
|
Pulse Biosciences
PLSE
|
6.72 M | $ 25.77 | 3.74 % | $ 1.74 B | ||
|
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 10.47 | 2.05 % | $ 2.09 B | ||
|
Retractable Technologies
RVP
|
2.38 M | $ 0.69 | 0.16 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
9.93 M | $ 65.0 | - | $ 214 M | ||
|
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | ||
|
Stereotaxis
STXS
|
1.65 M | $ 1.85 | 2.21 % | $ 168 M | ||
|
Baxter International
BAX
|
7.05 B | $ 20.03 | 4.16 % | $ 10.3 B | ||
|
ResMed
RMD
|
1.05 B | $ 196.94 | 1.97 % | $ 28.8 B | ||
|
AtriCure
ATRC
|
261 M | $ 27.3 | 1.43 % | $ 1.3 B | ||
|
Harvard Bioscience
HBIO
|
58.5 M | $ 6.04 | 0.5 % | $ 268 M | ||
|
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
148 M | $ 12.34 | 3.44 % | $ 504 M | ||
|
Becton, Dickinson and Company
BDX
|
25 B | $ 152.04 | 2.08 % | $ 43.7 B | ||
|
Nephros
NEPH
|
1.61 M | $ 3.25 | -4.13 % | $ 34.5 M | ||
|
OraSure Technologies
OSUR
|
22.5 M | $ 4.24 | 2.17 % | $ 312 M | ||
|
Repligen Corporation
RGEN
|
708 M | $ 130.13 | 3.83 % | $ 7.32 M |